Stanford University
Showing 27,021-27,040 of 34,448 Results
-
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Serena Shah
Ph.D. Student in History, admitted Autumn 2021
GRAD Research Assistant, History DepartmentBioI am a PhD candidate in U.S. History. I study the history of ideas and the production of knowledge in our major cultural institutions, especially universities and museums. I specialize in the history of the late nineteenth and early twentieth centuries.
My dissertation, "American Orientalism and Liberal Education: Building Moral Responsibility in the Gilded Age," examines an early defense of liberal education mounted by scholars at elite research universities after the Civil War. These scholars, who called themselves "orientalists," invented the idea of “Western civilization" and argued that the origins of the West lay in the ancient Orient (the region roughly corresponding to the modern Middle East). In an age of moral crisis, orientalists and academic leaders made the case that it was the role of the university to train the nation’s young people in an unbroken story of human progress, and to create responsible, informed citizens capable of participation in a functioning democracy.
I also study Americans' ideas about antiquity more broadly in the long nineteenth century. I am in the process of publishing a research article on Greek and Roman slave-naming practices and the classicism of American slavery. The study centers around a database of tens of thousands of slave names that I have compiled from archives across the American South. -
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, bladder, kidney, and testicular cancers. He is actively involved in clinical trials, with a particular focus on novel immunotherapy agents and biomarkers to select patients most likely to benefit from therapy. His academic interests also encompass digital health technologies and innovative healthcare delivery models. He has lectured internationally on the management of urologic cancers and currently serves on the National Cancer Center Network (NCCN) Panel for testicular cancer.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Healthcare Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Yash Shah
Ph.D. Student in Computer Science, admitted Autumn 2025
Current Research and Scholarly InterestsMy research interests lie in developing neuroconnectionist mechanistic models of the brain that deepen our understanding of neural computation and representations. I aim to explore how physiological and anatomical constraints shape cortical topography and, in turn, scaffold development. I am particularly intrigued by observing certain behaviors emerge from mechanistic models, even when the model was not optimized to do so.
-
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
